Med Mal RRG Inc
Major Rating Factors:
Weak overall results on stability tests (2.2 on a scale of 0 to 10) including weak risk adjusted capital in prior years, weak risk diversification and negative cash flow from operations for 2024. The largest net exposure for one risk is excessive at 5.1% of capital. Good long-term capitalization index (6.1) based on good current risk adjusted capital (moderate loss scenarios) reflecting significant improvement over results in 2023. Fair profitability index (3.9) with operating losses during 2020, 2021, 2022 and the first three months of 2025. Return on equity has been low, averaging 2.7% over the past five years.
Other Rating Factors:
History of adequate reserve strength (6.0) as reserves have been consistently at an acceptable level. Superior liquidity (10.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
TN
Principal Investments:
Investment grade bonds (39.6%), common stock (38.0%), cash (22.4%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
522 Brandies Circle
Murfreesboro, TN 37128
Murfreesboro, TN 37128
Phone Number
(615) 610-7010
NAIC Number
14446
Website
--
Largest Affiliates
No affiliate information available.